What is the common brand name(s) for:
allopurinol
(al-oh-PURE-i-nol)
Zyloprim
Class: Xanthine oxidase inhibitor
Indication: Used for gout, hyperuricemia in cancer patients, prevention of gouty arthritis and urate nephropathy, nephrolithiasis prevention, and tumor lysis syndrome
MOA: Competitive inhibitor of xanthine oxidase, converted to active metabolite oxypurinol in the liver, decreases uric acid excretion, increases urinary excretion of hypoxanthine
Side effects: skin rash; nausea/vomiting; diarrhea; hepatic toxicity; agranulocytosis; alopecia; drowsiness; rare: Stevens-Johnson syndrome; DRESS syndrome; hair discoloration
Contraindications: Known HLA-B*5801-positive
Considerations:
What is the common brand name(s) for:
canagliflozin
(ka-na-GLIF-loe-zin)
Invokana
Class: SGLT2 inhibitors
Indication: Used for Diabetes Mellitus Type 2, as monotherapy or with other antidiabetic medications
MOA: Inhibits SGLT2 in the renal PCT, decreasing renal glucose reabsorption and increasing urinary glucose excretion
Side effects: weight loss; hypotension; dyslipidemia; nausea; increased thirst and dehydration; increased incidence of UTI and genital yeast infections; increased risk of osteoporosis and fractures; diabetic ketoacidosis
Contraindications: Hypersensitivity to drug or its components
Considerations:
What is the common brand name(s) for:
cinacalcet
(sin-a-KAL-set)
Sensipar
Class: Calcimimetic agent
Indication: Used for primary and secondary hyperparathyroidism, hypercalcemia
MOA: Increases sensitivity of calcium-sensing receptors on parathyroid cells, reducing PTH secretion and lowering serum calcium levels
Side effects: nausea; vomiting; paresthesias; muscle cramps; cardiac arrhythmias
Contraindications: Hypocalcemia
Considerations:
What is the common brand name(s) for:
colchicine
(KOL-chi-seen)
Gloperba
Class: Anti-gout agent
Indication: Used for acute gout, prophylaxis during allopurinol loading, familial Mediterranean fever, and atherosclerotic cardiovascular disease risk reduction
MOA: Disrupts microtubules and inhibits inflammatory leukocyte motility, blocking urate crystal-induced joint inflammation
Side effects: nausea; vomiting; diarrhea; abdominal cramps; agranulocytosis; alopecia; increased risk of GI bleeds
Contraindications: Severe renal or hepatic impairment; strong CYP3A4 inhibitor; blood dyscrasias
Considerations:
What is the common brand name(s) for:
dapagliflozin
(dap-a-GLIF-loe-zin)
Farxiga
Class: SGLT2 inhibitors
Indication: Used for Diabetes Mellitus Type 2, chronic kidney disease, heart failure
MOA: Inhibits SGLT2 in the renal PCT, decreasing renal glucose reabsorption and increasing urinary glucose excretion
Side effects: weight loss; hypotension; dyslipidemia; nausea; increased thirst and dehydration; increased incidence of UTI and genital yeast infections; increased risk of osteoporosis and fractures; diabetic ketoacidosis
Contraindications: Ketoacidosis; caution if dehydrated, hypotension, on antihypertensives, diuretics, or ACE inhibitors; elevated hematocrit
Considerations:
What is the common brand name(s) for:
darbepoetin
(dar-be-POE-e-tin)
Aranesp
Class: Erythropoiesis-Stimulating Agent (ESA)
Indication: Used for anemia due to chronic kidney disease and chemotherapy
MOA: Binds to erythropoietin receptors on bone marrow, increasing red blood cell production and maturation
Side effects: hypertension; edema; fatigue; nausea; vomiting; headache; arthralgia; injection site reactions; serious: increased risk of cardiovascular events; thromboembolic events; pure red cell aplasia; tumor progression; seizures
Contraindications: Uncontrolled hypertension; pure red cell aplasia; cancer patients not undergoing chemotherapy; severe renal failure not on dialysis
Considerations:
What is the common brand name(s) for:
desiccated thyroid
(DES-i-kay-ted THY-roid)
Armour Thyroid
Class: Animal thyroid hormones
Indication: Used for hypothyroidism
MOA: Dried thyroid gland tissue mimics endogenous T3 and T4 action
Side effects: weight loss; increased appetite; insomnia; headache; nervousness; tremors; heat intolerance; excessive sweating; hyperthyroidism; decreased bone density
Contraindications: Untreated thyrotoxicosis; uncorrected adrenal insufficiency
Considerations:
What is the common brand name(s) for:
dulaglutide
(doo-la-GLOO-tide)
Trulicity
Class: GLP-1 agonists
Indication: Used for Diabetes Mellitus Type 2, usually with other oral antidiabetic drugs
MOA: Enhances GLP-1 effect by binding to GLP1Rs, stimulating glucose-dependent insulin secretion, increasing glucose uptake, decreasing glucagon secretion, delaying gastric emptying, increasing satiety
Side effects: decreased appetite; asthenia; dry mouth; dizziness; nausea; vomiting; headache; gallbladder disorders; acute pancreatitis
Contraindications: Personal or family history of medullary thyroid carcinoma with multiple endocrine neoplasia syndrome type 2
Considerations:
What is the common brand name(s) for:
empagliflozin
(em-pa-GLIF-loe-zin)
Jardiance
Class: SGLT2 inhibitors
Indication: Used for Diabetes Mellitus Type 2, chronic kidney disease, heart failure
MOA: Inhibits SGLT2 in the renal PCT, decreasing renal glucose reabsorption and increasing urinary glucose excretion
Side effects: weight loss; hypotension; increased thirst and dehydration; increased incidence of UTI and genital yeast infections; increased risk of osteoporosis and fractures; diabetic ketoacidosis
Contraindications: Hypersensitivity to drug or its components
Considerations:
What is the common brand name(s) for:
epoetin alfa
(E-poe-e-tin AL-fa)
Epogen, Procrit
Class: Erythropoiesis-Stimulating Agent (ESA)
Indication: Used for anemia due to chemotherapy, chronic kidney disease, and zidovudine use; reduces need for allogeneic RBC transfusion
MOA: Stimulates erythropoiesis by binding to erythropoietin receptors and increasing hemoglobin levels
Side effects: hypertension; headache; nausea; fever; edema; injection site reactions; increased risk of thrombotic events; seizures; pure red cell aplasia
Contraindications: Uncontrolled hypertension; pure red cell aplasia; neonates; infants; pregnant; and breastfeeding for multidose vials
Considerations:
What is the common brand name(s) for:
exenatide
(ex-EN-a-tide)
Byetta, Bydureon
Class: Incretin mimetics
Indication: Used for Diabetes Mellitus Type 2 as an adjunct medication with diet and exercise
MOA: Binds GLP-1 receptors, stimulating the adenylyl cyclase pathway to produce insulin in pancreatic beta-cells, resulting in increased insulin, decreased glucagon, and delayed gastric emptying
Side effects: decreased appetite; weight loss; nausea; vomiting; constipation; diarrhea; asthenia; headache; dizziness; injection site reactions; severe pancreatitis (rare)
Contraindications: History or family history of medullary thyroid carcinoma; Multiple endocrine neoplasia syndrome type 2; History of drug-induced immune-mediated thrombocytopenia
Considerations:
What is the common brand name(s) for:
febuxostat
(fe-BUK-soe-stat)
Uloric
Class: Xanthine Oxidase Inhibitor
Indication: Used for treating gout
MOA: Inhibits xanthine oxidase, the enzyme responsible for changing hypoxanthine to xanthine to uric acid, helping to decrease uric acid in the body
Side effects: Decreased appetite, weight loss, nausea, vomiting, constipation, diarrhea, asthenia, headache, dizziness, and injection site reactions; severe pancreatitis (rare)
Contraindications: Use with azathioprine or mercaptopurine
Considerations:
What is the common brand name(s) for:
glimepiride
(glim-EP-i-ride)
Amaryl
Class: Sulfonylureas
Indication: Used for treating Diabetes Type 2
MOA: Inhibits ATP-sensitive K+ channels, preventing K+ efflux and causing Ca2+ influx and activation of pulsatile insulin secretion. No effect on basal insulin secretion. Limits hepatic gluconeogenesis and lipolysis. Increases insulin sensitivity in DM2.
Side effects: weight gain; hypoglycemia; skin rashes; nausea; vomiting; abdominal pain; cholestasis; hematologic reactions
Contraindications: Hypersensitivity to the drug or any of its components
Considerations:
What is the common brand name(s) for:
glipizide
(GLIP-i-zide)
Glucotrol
Class: Sulfonylureas
Indication: Used for treating Diabetes Type 2
MOA: Inhibits ATP-sensitive K+ channels, preventing K+ efflux and causing Ca2+ influx and activation of pulsatile insulin secretion. No effect on basal insulin secretion. Limits hepatic gluconeogenesis and lipolysis. Increases insulin sensitivity in DM2.
Side effects: weight gain; hypoglycemia; skin rashes; nausea; vomiting; abdominal pain; cholestasis; hematologic reactions
Contraindications: Type 1 diabetes mellitus; diabetic ketoacidosis (with or without coma)
Considerations:
What is the common brand name(s) for:
glyburide
(GLYE-byoor-ide)
Micronase, Diabeta
Class: Sulfonylureas
Indication: Used for Diabetes Type 2 as monotherapy or in combination with metformin
MOA: Inhibits ATP-sensitive K+ channels, preventing K+ efflux and causing Ca2+ influx and activation of pulsatile insulin secretion. No effect on basal insulin secretion. Limits hepatic gluconeogenesis and lipolysis. Increases insulin sensitivity in DM2.
Side effects: weight gain; hypoglycemia; skin rashes; nausea; vomiting; abdominal pain; cholestasis; hematologic reactions
Contraindications: Type 1 diabetes mellitus; diabetic ketoacidosis (with or without coma); use with bosentan
Considerations:
What is the common brand name(s) for:
hydroxychloroquine
(hye-DROX-ee-klor-oh-kwin)
Plaquenil
Class: Antimalarial, DMARD
Indication: Used for prophylaxis and treatment of malaria, rheumatoid arthritis, and lupus
MOA: Precise mechanism is unconfirmed; hypothesized to raise lysosomal pH within malaria parasites, preventing hemoglobin proteolysis and thus preventing parasite replication; also raises pH within APCs, reducing antigen presentation and dampening the immune inflammatory response
Side effects: abdominal pain; diarrhea; decreased appetite; nausea and vomiting; headache; QT prolongation; rare side effects include visual impairment; tinnitus; retinopathy; vertigo; corneal edema; arrhythmias; seizures
Contraindications: Hypersensitivity to the drug or any of its components
Considerations:
What is the common brand name(s) for:
insulin aspart
(IN-soo-lin AS-part)
NovoLog
Class: Rapid-acting insulin
Indication: Used to manage Diabetes Mellitus Type 1 and Type 2.
MOA: Rapid-acting insulin analog that binds to the insulin receptor, mimicking the endogenous effects of insulin.
Side effects: hypoglycemia; edema; weight gain; hypokalemia; lipodystrophy at injection site (uncommon)
Contraindications: Hypersensitivity to the drug or any of its components.
Considerations:
What is the common brand name(s) for:
insulin degludec
(IN-soo-lin DE-glue-dek)
Tresiba
Class: Ultra long-acting insulin
Indication: Used for Diabetes Type 1 and Type 2 management.
MOA: Acts via membrane-bound receptors on target tissue (liver, muscle, adipose tissue) to regulate metabolism of carbohydrate, proteins, and fats.
Side effects: hypoglycemia; edema; weight gain; hypokalemia; lipodystrophy at injection site (uncommon)
Contraindications: Hypersensitivity to the drug or any of its components.
Considerations:
What is the common brand name(s) for:
insulin detemir
(IN-soo-lin DET-eh-meer)
Levemir
Class: Long-acting insulin
Indication: Used for Diabetes Mellitus Type 1 and Type 2.
MOA: Binds to insulin receptors, lowering blood glucose by stimulating cellular uptake of glucose and by inhibiting the output of glucose from the liver.
Side effects: Hypoglycemia, edema, weight gain, hypokalemia, lipodystrophy at injection site (uncommon).
Contraindications: Hypoglycemia episode, asthma, COPD (inhalation powder).
Considerations:
What is the common brand name(s) for:
insulin glargine
(IN-soo-lin GLAR-jeen)
Class: Long-acting insulin
Indication: Used for Diabetes Mellitus Type 1 and Type 2.
MOA: Provides basal levels of insulin and facilitates control of glycemia throughout the day.
Side effects: Hypoglycemia, edema, weight gain, hypokalemia, lipodystrophy at injection site (uncommon).
Contraindications: Hypoglycemia episode.
Considerations:
What is the common brand name(s) for:
insulin glulisine
(IN-soo-lin GLOO-li-seen)
Apidra
Class: Rapid-acting insulin
Indication: Used for Diabetes Mellitus Type 1 and Type 2.
MOA: Rapid-acting insulin analog that binds to the insulin receptor, mimicking the endogenous effects of insulin.
Side effects: hypoglycemia; edema; weight gain; hypokalemia; lipodystrophy at injection site (uncommon)
Contraindications: Hypersensitivity to the drug or any of its components.
Considerations:
What is the common brand name(s) for:
insulin isophane
Neutral Protamine Hagedorn (NPH)
(IN-soo-lin EYE-soe-fane – NOO-tral PRO-ta-meen HAG-er-dorn)
Humulin N, Novolin N
Class: Insulin analog, intermediate-acting
Indication: Used for Diabetes Mellitus Type 1 and Type 2.
MOA: Consists of particles of insulin combined with zinc, protamine, and phenol.
Side effects: hypoglycemia; edema; weight gain; lipodystrophy (rare)
Contraindications: Hypoglycemia episode
Considerations:
What is the common brand name(s) for:
insulin lispro
(IN-soo-lin LIS-pro)
Humalog
Class: Rapid-acting insulin
Indication: Used for Diabetes Mellitus Type 1 and Type 2.
MOA: Rapid-acting insulin analog that binds to the insulin receptor, mimicking the endogenous effects of insulin.
Side effects: hypoglycemia; edema; weight gain; hypokalemia; lipodystrophy at injection site (uncommon)
Contraindications: Hypoglycemia episode
Considerations:
What is the common brand name(s) for:
insulin regular
(IN-soo-lin REG-yoo-lar)
Humulin R, Novolin R
Class: Insulin
Indication: Used for Diabetes Mellitus Type 1 and Type 2.
MOA: Acts via membrane-bound receptors on target tissue (liver, muscle, adipose tissue) to regulate metabolism of carbohydrate, proteins, and fats.
Side effects: hypoglycemia; edema; weight gain; lipodystrophy (rare)
Contraindications: Hypersensitivity to the drug or any of its components.
Considerations: